Pharmacological Properties, Molecular Mechanisms, and Pharmaceutical Development of Asiatic Acid: A Pentacyclic Triterpenoid of Therapeutic Promise
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Asiatic acid (AA) is a naturally occurring aglycone of ursane type pentacyclic triterpenoids from a tropical plant, Centella asiatica, reputed in traditional medicine for wound healing, neurodegenerative diseases and cancer. AA possesses numerous pharmacological activities such as antioxidant and anti-inflammatory and regulates apoptosis, which contribute to its therapeutic effects. It also showed antihypertensive, nootropic, antimicrobial and antitumor activities in preclinical studies. AA has been found to affect many enzymes, receptors, growth factors, transcription factors, apoptotic proteins and cell signaling cascades. This review comprehensively represents the available scientific reports on therapeutic potential and the underlying pharmacological and molecular mechanisms of AA. The review also deliberates pharmacokinetics, physicochemical properties, analysis and structural modifications in the pharmaceutical development of AA. The article also discusses the challenges and prospects on the pharmaceutical and clinical development of AA with a pharmacological basis of its use in therapeutics against numerous diseases inducing cardiovascular, neurological, dermatological, rheumatic, gastrointestinal, and metabolic and malignancy. The article also emphases on the pharmacokinetics, physicochemical properties, drug delivery and ways of its pharmaceutical development as an agent or adjuvant along with currently used modern medicines to maximise efficacy and safety. Based on the available literature highlighting the pharmacological properties, therapeutic potential and molecular mechanisms AA appears one of the important pleiotropic multitargeted agent of natural origin for further pharmaceutical development and clinical application.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gurtner, G. C., Werner, S., Barrandon, Y., & Longaker, M. T. (2008) · Nature · doi:10.1038/nature07039 · Cited by 6,542
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome
Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L. (2001) · Diabetes Care · doi:10.2337/diacare.24.4.683 · Cited by 4,760
Malignant astrocytic glioma: genetics, biology, and paths to treatment
Furnari, F. B., Fenton, T., Bachoo, R. M., Mukasa, A., Stommel, J. M., Stegh, A., Hahn, W. C., Ligon, K. L., Louis, D. N., Brennan, C., et al. (2007) · Genes & Development · doi:10.1101/gad.1596707 · Cited by 2,316
Mechanisms of photoaging and chronological skin aging
Fisher, G. J., Kang, S., Varani, J., Bata-Csorgo, Z., Wan, Y., Datta, S., & Voorhees, J. J. (2002) · Archives of Dermatology · doi:10.1001/archderm.138.11.1462 · Cited by 1,849
Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies
Gauglitz, G. G., Korting, H. C., Pavicic, T., Ruzicka, T., & Jeschke, M. G. (2011) · Molecular Medicine · doi:10.2119/molmed.2009.00153 · Cited by 1,462
An analysis of the attrition of drug candidates from four major pharmaceutical companies
Waring, M. J., Arrowsmith, J., Leach, A. R., Leeson, P. D., Mandrell, S., Owen, R. M., Pairaudeau, G., Pennie, W. D., Pickett, S. D., Wang, J., et al. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4609 · Cited by 1,450
Pentacyclic Triterpenoids from the Medicinal Herb, Centella asiatica (L.) Urban
James, J. T., & Dubery, I. A. (2009) · Molecules · doi:10.3390/molecules14103922 · Cited by 399
Wu, S., & Tian, L. (2017) · Molecules · doi:10.3390/molecules22101606 · Cited by 235
Somboonwong, J., Kankaisre, M., Tantisira, B., & Tantisira, M. H. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-103 · Cited by 232
Cited by
Therapeutic Potential of Centella asiatica and Its Triterpenes: A Review
Sun, B., Wu, L., Wu, Y., Zhang, C., Qin, L., Hayashi, M., Kudo, M., Gao, M., & Liu, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.568032 · Cited by 353
The role of Toll-like receptors and neuroinflammation in Parkinson’s disease
Heidari, A., Yazdanpanah, N., & Rezaei, N. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02496-w · Cited by 275
Centella asiatica: Secondary metabolites, biological activities and biomass sources
Kunjumon, R., Johnson, A. J., & Baby, S. (2022) · Phytomedicine Plus · doi:10.1016/j.phyplu.2021.100176 · Cited by 79
Tan, S. C., Bhattamisra, S. K., Chellappan, D. K., & Candasamy, M. (2021) · Applied Sciences · doi:10.3390/app11188475 · Cited by 72
Chitosan-based microneedle arrays for dermal delivery of Centella asiatica
Ryall, C., Chen, S., Duarah, S., & Wen, J. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122221 · Cited by 65
Han, A.-R., Lee, S., Han, S., Lee, Y. J., Kim, J.-B., Seo, E. K., & Jung, C.-H. (2020) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2020/3683460 · Cited by 28
Suryavanshi, J., Prakash, C., & Sharma, D. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-00998-3 · Cited by 27
Opatha, S. A. T., Chutoprapat, R., Khankaew, P., Titapiwatanakun, V., Ruksiriwanich, W., & Boonpisuttinant, K. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.123738 · Cited by 25
Chutoprapat, R., Witarat, J., Jongpanyangarm, P., Mang Sung Thluai, L., Khankaew, P., & Wah Chan, L. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.123980 · Cited by 11
Metadata
- Authors
- Nagoor Meeran, M. F., Goyal, S. N., Suchal, K., Sharma, C., Patil, C. R., & Ojha, S. K.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-09-04
- Volume
- 9
- Pages
- 892-892
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2883058578
- Cited by
- 196
- References
- 25
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.